Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

First clinical results reported for NPS-1506

May 1, 1998

LY-300164 suppresses kindling-induced seizures in mice

May 1, 1998

Lamotrigine evaluated for the treatment of childhood autism

May 1, 1998

Beneficial effects of tolcapone on sleep disturbances in parkinsonian patients

May 1, 1998

Potent calpain inhibitors disclosed by Mitsubishi Chem.

May 1, 1998

Intrathecal SNX-111 for acute postoperative pain

April 30, 1998

Dopaminergic compound CI-1007 evaluated in schizophrenic patients

April 30, 1998

Patient dosing begins in trial of Allelix's selective serotonin agonist

April 30, 1998

Another series of substance P antagonists discovered at Pfizer

April 30, 1998

ABT-431, an improved therapeutic option for PD

April 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...